Kalaris Therapeutics, Inc. (KLRS) › RevenueKalaris Therapeutics, Inc. (KLRS) — RevenueAnnual figures by period end, from SEC filings.Period endedRevenueChange YoYSource filing2019-12-31$165.0K—2021-02-12From 2019-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)